Login
From:
Fragile X News Today
(Uncensored)
subscribe
Trial of psilocybin microdose therapy in fragile X cleared in Canada | KGK Science trial to test NM-1001 in up to 10 patients | Fragile X News Today
https://fragilexnewstoday.com/news/trial-psilocybin-microdose-therapy-fragile-x-cleared-canada/
links
backlinks
Tagged with:
clinical trial
psilocybin microdose
kgk science
nm-1001
The Canadian government has cleared KGK Science's Phase 2a trial testing NM-1001, a psilocybin microdose therapy, in fragile X syndrome.
Roast topics
Find topics
Find it!
